Keyphrases
Atrial Fibrillation
100%
Stable Coronary Artery Disease
72%
Liraglutide
49%
Hazard Ratio
46%
All-cause Mortality
43%
Heart Rate Variability
42%
Middle-aged
39%
Heart Disease
34%
Coronary Artery Disease
34%
Confidence Interval
34%
Type 2 Diabetes Mellitus (T2DM)
31%
Patients with Coronary Artery Disease
30%
Placebo
30%
Ischemic Stroke
26%
Early Onset
26%
Acute Myocardial Infarction
25%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
25%
Copenhagen
25%
Infarction
24%
New-onset Type 2 Diabetes
23%
Cardiovascular Events
23%
10-year Follow-up
22%
Risk Factors
22%
Acute Heart Failure
22%
Aortic Stenosis
22%
Elderly Subjects
22%
Verapamil
22%
Systolic Blood Pressure
21%
Heart Rate
21%
Metformin
21%
Older Subjects
21%
Heart Failure
21%
Stroke Risk
20%
Poor Prognosis
20%
Incident Atrial Fibrillation
20%
Placebo-controlled
20%
Clarithromycin
19%
Randomized Double-blind
19%
Ectopic Activity
18%
Prognostic Value
18%
Cardiovascular Mortality
18%
Community-dwelling
17%
Prospective Cohort Study
17%
C-reactive Protein
16%
Glucagon-like
16%
Silent Myocardial Ischemia
16%
Non-severe
16%
Exome
16%
Population-based
16%
Hypokalemia
16%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
82%
Non Insulin Dependent Diabetes Mellitus
49%
Placebo
49%
Atrial Fibrillation
40%
Liraglutide
38%
All Cause Mortality
37%
C Reactive Protein
37%
Ischemic Heart Disease
37%
Heart Disease
32%
Brain Natriuretic Peptide
27%
Infarction
24%
Acute Heart Infarction
23%
Cohort Study
23%
Cardiovascular Risk
22%
Verapamil
22%
Aortic Stenosis
22%
Clarithromycin
21%
Heart Infarction
20%
Troponin T
19%
Acute Heart Failure
16%
Hypokalemia
16%
Heart Failure
15%
Metformin
15%
Glucagon Like Peptide 1 Receptor Agonist
14%
Obesity
13%
Inflammation
13%
Heart Ventricle Extrasystole
12%
Heart Arrhythmia
12%
Isotopes of Potassium
11%
Long Term Exposure
11%
Cardiovascular Disease
11%
Biological Marker
11%
Statin (Protein)
11%
Silent Myocardial Ischemia
11%
Hyponatremia
11%
Diabetes Mellitus
10%
Cause of Death
8%
Endostatin
7%
Cathepsin S
7%
Pregnancy Associated Plasma Protein A
7%
Osteoprotegerin
7%
Cathepsin B
7%
Mortality Rate
7%
Population Study
7%
Unstable Angina Pectoris
7%
Observational Study
6%
Tumor Necrosis Factor Receptor 2
6%
Tumor Necrosis Factor Receptor 1
6%
Randomized Clinical Trial
6%
Prevalence
6%
Medicine and Dentistry
Atrial Fibrillation
66%
Coronary Artery Disease
52%
Apoplexy
49%
Liraglutide
44%
Maturity Onset Diabetes of the Young
40%
Middle Age
31%
Hazard Ratio
30%
Heart Rate Variability
28%
Placebo
27%
Cardiovascular System
23%
All Cause Mortality
22%
Heart Disease
22%
Aortic Stenosis
22%
Brain Ischemia
20%
Glycon
18%
Blood Pressure
16%
Silent Myocardial Ischemia
16%
Acute Heart Infarction
16%
Glucagon-Like Peptide-1 Agonist
15%
Patient with Type 2 Diabetes
15%
Systolic Blood Pressure
14%
Computer Assisted Tomography
14%
Population
14%
C Reactive Protein
14%
Electrocardiogram
13%
Nonsustained Ventricular Tachycardia
12%
Prevalence
12%
Acute Decompensated Heart Failure
12%
Cohort Analysis
12%
Dyspnea
12%
Echocardiography
12%
Beta Cell
11%
Prospective Cohort Study
11%
Heart Failure
11%
Lung Congestion
11%
P Wave
11%
Aortic Valve Stenosis
11%
Hypokalemia
11%
Hyponatremia
11%
Cell Function
10%
Obesity
10%
Cardiovascular Disease
10%
Troponin T
9%
Diabetes Mellitus
8%
Holter Monitoring
8%
Emergency Department
7%
Fibrosis
7%
Premature Ventricular Contraction
7%
Arrhythmia
7%
Cardiovascular Risk
7%
